1. Introduction {#s1}
===============

Cardiovascular (CV) diseases are the most common causes of death and causes frequent hospital admissions.[@b1] The increase in life expectancy and the appearance of new treatments,[@b2] is changing in the clinical profile of CV disease, with a rise in chronic processes and concomitant comorbidities.[@b3] These changes are probably reflected in the current profile of patients admitted to cardiology departments, and in their causes of mortality.

The coronary care units emerged at the end of the 1960s,[@b4] with the aim of improving the care provided to patients with acute myocardial infarction. With the generalization of these units, there has been an important evolution and a great diversification of patients and diagnoses of admission. The causes of mortality in these units, as well as the treatment administered, invasive procedures or palliative interventions could differ from patients who are admitted to the conventional hospitalization ward. Most of the studies concerning the mode of death in cardiology departments are old, previous to reperfusion era[@b5]--[@b7] or do not address current important issues, such as end-of-life decisions regarding therapeutic support.[@b4],[@b8]

Our main objective was to characterize the causes of death, the therapeutic support, and decisions on life-sustaining therapies at the end-of-life. We also aimed to determine the independent predictors associated with a higher likelihood of receiving comfort measures or a palliative intervention at the end-of-life.

2. Methods {#s2}
==========

2.1. Data collection {#s2a}
--------------------

We performed an observational retrospective study, including all deaths that took place in the cardiology department of an academic hospital during a 5-years period (from 1^st^ January, 2013 to 31^st^ December, 2017). Data were extracted from hospital administrative lists, and information related with the hospital admission and mode of death was collected from the medical electronic records or autopsy reports (when available).

Patients were classified according the place of death (intensive cardiac care unit or conventional ward). The variables reported include demographic data, patients\' previous medical history, and diagnoses at admission. Mortality causes were classified as CV or non-CV, according to the previous definitions of the Standardized Data Collection for CV Trials Initiative (SCTI) and the U.S. Food and Drug Administration (FDA).[@b9] We made a distinction between primary (underlying disease that started the chain of events resulting in death) and intervening causes of death (other conditions that contribute to death).[@b9] Regarding in hospital treatment, the variables recorded included "do-not-resuscitate" orders, palliative measures/comfort medications (defined as interventions that provide immediate symptoms relief in patients close to death), and invasive life-sustaining therapies (renal replacement therapy, intra-aortic balloon pump, mechanical ventilation, or inotropes). We also differentiated between patients with a previous "do-not-resuscitate" order and unexpected deaths (those occurring in patients with on-going therapeutic efforts). Limitation of therapeutic effort was defined as the decision based on the status and prognosis of a patient to not apply treatments or perform procedures that would prolong agony.[@b10]

2.2. Statistical analysis {#s2b}
-------------------------

Quantitative variables are presented as mean ± SD, or median (interquartile rank) for non-normally distributed variables. Categorical variables are presented as frequencies and percentages. Continuous quantitative variables were compared using Student\'s *t*-test and ANOVA for the comparison of means or the Wilcoxon rank sum in non-parametric data, and the categorical variables with the *χ*^2^ test and the Fischer exact test. Bonferroni\'s correction was applied for multiple comparisons. A significance level of 0.05 (bilateral) was set for all statistical tests. Multivariate analysis included multiple logistic regression modelling techniques, for the primary endpoints. To determine which variables were entered into the final model, we used a sequential inclusion and exclusion method, with an inclusion p threshold lower than 0.05 and exclusion over than 0.1. All analyses were performed with the STATA software (Version 14.0).

This study accomplishes with the Declaration of Helsinki and was approved by the Ethics Committee of Clinical Investigation, Hospital Universitario Gregorio Marañón, Madrid, Spain.

3. Results {#s3}
==========

During the study period a total of 500 deaths were recorded in our cardiology department. Mean age was 74.2 ± 13.1 years, and 186 (37.2%) were women. The more common diagnoses at admission were heart failure 181 (36.2%) and cardiac arrest 145 (29.0%). The clinical profile according to the diagnoses of admission is depicted in [Table 1](#jgc-16-06-482-t01){ref-type="table"}. CV causes of death were found as the primary cause of mortality in 407 patients (81.4%). Non-CV causes were the leading cause of mortality in 93 patients (18.6%), and acted as an intervening cause of death in 182 (36.4%). Therefore, globally, a non-CV cause played a role in 275 patients (55.0%). [Table 1](#jgc-16-06-482-t01){ref-type="table"} also describes the therapeutic efforts according to the diagnosis of admission. Patients with heart failure received more frequently a limitation of therapeutic effort, a less aggressive treatment, and more comfort measures compared to the rest of diagnoses of admission. Patients who were admitted for heart failure decompensation had an advanced age, presented frequent comorbidities and often had a non-cardiac cause of mortality \[especially infections 41 patients (39.8%)\]. Other less common causes of death included mechanical complications of acute coronary syndromes in 23 patients, pulmonary embolism in 10 patients, periprocedural complications in 6 patients, and bradycardia in 2 patients (in both cases a conservative approach was preferable due to advanced age and dementia).

###### Basal demographic characteristics, previous medical history and mortality-related factors according to admission diagnosis.

  Variables                                                                                   Total (*n* = 500)   Acute coronary syndromes (*n* = 115)   Cardiac arrest (*n* = 145)   Heart failure (*n* = 181)   Others^\*^ (*n* = 59)   *P*-value
  ------------------------------------------------------------------------------------------ ------------------- -------------------------------------- ---------------------------- --------------------------- ----------------------- -----------
  Age, yrs                                                                                       74.2 ± 13.1                  78.1 ± 11.0                       69.7 ± 13.3                  73.6 ± 13.7               79.6 ± 9.6         \< 0.001
  Female sex                                                                                     186 (37.2%)                   49 (42.6%)                        38 (26.2%)                  68 (37.6%)                31 (52.5%)           0.002
  History of ischemic heart disease                                                              162 (32.5%)                   33 (28.9%)                        45 (31.0%)                  67 (37.0%)                17 (28.8%)           0.42
  History of valvular heart disease                                                              146 (29.4%)                   23 (20.2%)                        18 (12.5%)                  84 (46.9%)                21 (35.6%)         \< 0.001
  History of heart failure                                                                       183 (36.8%)                   16 (14.0%)                        26 (18.0%)                  113 (62.4%)               28 (47.5%)         \< 0.001
  Left ventricular ejection fraction                                                            39.3% ± 17.3%                35.2% ± 15.3%                     39.5% ± 16.7%                38.1% ± 17.8%             49.8% ± 16.8%       \< 0.001
  Atrial fibrillation                                                                            160 (32.2%)                   24 (21.1%)                        33 (23.1%)                  83 (45.9%)                20 (33.9%)         \< 0.001
  Chronic obstructive pulmonary disease                                                          116 (23.4%)                   19 (16.8%)                        40 (28.0%)                  48 (26.5%)                 9 (15.3%)           0.048
  Chronic kidney disease                                                                         182 (36.7%)                   34 (30.1%)                        34 (23.8%)                  91 (50.3%)                23 (39.0%)         \< 0.001
  Peripheral arterial disease                                                                    88 (17.7%)                    16 (14.2%)                        23 (16.1%)                  38 (21.0%)                11 (18.6%)           0.455
  Stroke with sequels                                                                            52 (10.5%)                    11 (9.7%)                         11 (7.7%)                   19 (10.5%)                11 (18.6%)           0.183
  Place of death                                                                                                                                                                                                                         
   Conventional ward                                                                             146 (29.2%)                   77 (67.9%)                       142 (97.9%)                  89 (49.2%)                46 (78.0%)        
   Coronary unit                                                                                 354 (70.8%)                   38 (33.0%)                         3 (2.1%)                   92 (50.8%)                13 (22.0%)         \< 0.001
  Length of hospital stay, days                                                                  13.5 ± 43.3                   8.6 ± 15.1                       12.2 ± 68.4                  19.7 ± 34.7                7.6 ± 9.7           0.093
  Death from cardiac causes (*n* = 407)                                                                                                                                                                                                  
  Death from cardiac causes                                                                      407 (81.4%)                  109 (94.8%)                        82 (56.6%)                  167 (92.3%)               49 (83.1%)         \< 0.001
   "Pump failure"                                                                                267 (65.8%)                   60 (55.1%)                        47 (57.3%)                  138 (83.1%)               22 (44.9%)         \< 0.001
   Severe coronary ischemia                                                                       8 (2.0%)                      7 (6.4%)                          1 (1.2%)                       \-                        \-            
   Sudden death                                                                                  90 (22.2%)                    21 (19.3%)                        26 (31.7%)                  27 (16.3%)                16 (32.7%)        
  Non-cardiac causes as primary cause of death or significant contributors (*n* = 275)\*\*                                                                                                                                               
   Septic shock/infection                                                                         77 (28%)                     13 (35.1%)                         6 (6.0%)                   41 (39.8%)                17 (48.6%)         \< 0.001
   Acute renal failure                                                                           47 (17.1%)                    9 (24.3%)                          5 (5.0%)                   28 (27.2%)                 5 (14.3%)        
   Brain death/Hypoxic-ischaemic encephalopathy                                                  79 (28.3%)                        0                             74 (74.0%)                   1 (1.0%)                  4 (11.4%)        
   Stroke                                                                                         17 (6.2%)                    4 (10.8%)                          3 (3.0%)                    5 (4.9%)                  5 (14.3%)        
   Respiratory                                                                                    23 (8.4%)                     3 (8.1%)                          8 (8.0%)                   11 (10.7%)                 1 (2.9%)         
   Gastrointestinal                                                                               17 (6.2%)                    5 (13.5%)                          2 (2.0%)                    7 (6.8%)                  3 (8.6%)         
  Patients with a "do-not-resuscitate" order                                                     392 (78.4%)                   80 (69.6%)                       114 (78.6%)                  158 (87.3%)               40 (67.8%)           0.001
  Comfort measures                                                                               329 (65.8%)                   68 (59.1%)                        91 (62.8%)                  140 (77.4%)               30 (50.9%)           0.001
  Vasoactive drugs during hospital admission                                                     387 (77.4%)                   84 (73.0%)                       138 (95.2%)                  122 (67.4%)               43 (72.9%)         \< 0.001
  Discontinuation of cardiac implantable defibrillator therapy (in defibrillator carriers)       14 (34.2%)                    2 (50.0%)                             0                        9 (33.3%)                 3 (60.0%)           0.209
  Mechanical ventilation                                                                         268 (53.6%)                   50 (43.5%)                       144 (99.3%)                  47 (26.0%)                27 (45.8%)         \< 0.001
  Non-invasive mechanical ventilation                                                            85 (17.0%)                    18 (15.7%)                         6 (4.1%)                   53 (29.3%)                 8 (13.8%)         \< 0.001
  Inotropes during admission                                                                     387 (77.4%)                   84 (73.0%)                       138 (95.2%)                  122 (67.4%)               43 (72.3%)         \< 0.001
  Mechanical circulatory support                                                                 91 (18.2%)                    37 (32.2%)                        27 (18.6%)                  20 (11.1%)                 7 (11.9%)         \< 0.001
  Temporary pacemaker                                                                             43 (8.6%)                    12 (10.4%)                         6 (4.1%)                    7 (3.9%)                 18 (30.5%)         \< 0.001
  Coronary angiography                                                                           215 (43.0%)                   81 (70.4%)                        78 (53.8%)                  39 (21.6%)                17 (28.8%)         \< 0.001
  Renal replacement therapy                                                                       48 (9.6%)                     8 (7.0%)                         10 (6.9%)                   24 (13.3%)                 6 (10.2%)           0.179
  Therapeutic hypothermia                                                                        59 (11.8%)                        0                             56 (38.9%)                   2 (1.1%)                  1 (1.7%)          \< 0.001
  Opioids during admission                                                                       372 (74.9%)                   76 (66.1%)                       110 (76.9%)                  155 (86.1%)               31 (52.5%)         \< 0.001
  Place of death                                                                                                                                                                                                                         
   Conventional ward                                                                             146 (29.2%)                   77 (67.9%)                         3 (2.1%)                   89 (49.2%)                46 (78.0%)        
   Coronary unit                                                                                 354 (70.8%)                   38 (33.0%)                       142 (97.9%)                  92 (50.8%)                13 (22.0%)         \< 0.001
  Length of hospital stay, days                                                                  13.5 ± 43.3                   8.6 ± 15.1                       12.2 ± 68.4                  19.7 ± 34.7                7.6 ± 9.7           0.093
  Number of days on mechanical ventilation                                                        4.3 ± 6.4                    4.6 ± 7.7                         3.8 ± 4.1                   6.0 ± 10.0                 2.6 ± 2.5           0.158

Data are presented as means ± SD or *n* (%). \*Bradycardia/atrio-ventricular block 20 patients, myocarditis 1 patient, pulmonary embolism 10 patients, septic shock 7 patients, cardiac tamponade 2 patients, elective interventional procedures 11 patients. \*\*Non-CV causes played a role in 275 patients (55.0%), non-CV causes were the leading cause of mortality in 93 patients (18.6%), and acted as an intervening cause of death in 182 (36.4%). CV: cardiovascular.

Most of the fatalities occurred in the cardiac intensive care unit \[354 patients (70.8%)\], and those patients\' clinical characteristics and mode of death were different from the ones that died in the cardiology ward ([Table 2](#jgc-16-06-482-t02){ref-type="table"}). Deaths in patients with a previous "do-not-resuscitate" order were more usual in the conventional ward compared to the cardiac intensive care unit \[131 patients (89.7%) *vs.* 261 patients (73.7%), *P* \< 0.001\]. Comfort therapies administration was also more common in the conventional ward \[121 patients (82.9%)\], compared to the cardiac intensive care unit \[208 patients (58.8%)\], *P* = 0.001. Finally, limitation in therapeutic effort before death was also more usual in the conventional ward \[121 patients (92.4%)\], than in the cardiac intensive care unit \[191 patients (73.2%)\], *P* \< 0.001.

###### Basal demographic characteristics, previous medical history and mortality-related factors according to the place of death.

  Variables                                                                                   Cardiac intensive care unit   Conventional ward   *P*-value
  ------------------------------------------------------------------------------------------ ----------------------------- ------------------- -----------
  Age, yrs                                                                                            72.4 ± 13.5              78.6 ± 10.7      \< 0.001
  Female sex                                                                                          127 (35.9%)              59 (40.4%)         0.342
  Hypertension                                                                                        250 (71.2%)              120 (82.2%)        0.009
  Diabetes                                                                                            129 (36.8%)              61 (41.8%)         0.547
  Functional Class \> II                                                                              50 (27.2%)               46 (51.7%)       \< 0.001
  History of ischemic heart disease                                                                   102 (28.9%)              60 (41.1%)         0.009
  Previous valvular heart disease                                                                     74 (21.1%)               72 (49.7%)       \< 0.001
  Previous heart failure admissions                                                                   96 (27.3%)               87 (59.6%)       \< 0.001
  Left ventricular ejection fraction                                                                 39.1% ± 17.3%            39.8% ± 17.4%      0.7243
  Atrial Fibrillation                                                                                 86 (24.5%)               74 (50.7%)       \< 0.001
  Cardiac devices                                                                                                                              
   Conventional pacemaker                                                                              21 (6.0%)               25 (17.1%)       \< 0.001
   Implantable cardioverter defibrillator                                                              20 (5.7%)                14 (9.6%)      
  Chronic kidney disease                                                                              103 (29.4%)              79 (54.1%)       \< 0.001
  Peripheral arterial disease                                                                         61 (17.4%)               27 (18.5%)         0.77
  Stroke with sequels                                                                                  33 (9.4%)               19 (13.1%)         0.261
  Mild to moderate cognitive decline                                                                   23 (6.6%)                14 (9.6%)         0.262
  Most common diagnoses at admission                                                                                                           
   Acute coronary syndrome                                                                            77 (21.8%)               38 (26.0%)       \< 0.001
   Cardiac arrest                                                                                     142 (40.1%)               3 (2.1%)       
   Heart failure                                                                                      89 (25.1%)               92 (63.0%)      
  Death from cardiac causes (*n* = 407)                                                                                                        
  Death from cardiac causes                                                                           269 (76.0%)              138 (94.5%)      \< 0.001
   "Pump failure"/Cardiogenic shock                                                                   158 (59.0%)              109 (79.0%)      \< 0.001
   Severe coronary ischemia                                                                            5 (1.9%)                 3 (2.2%)       
   Sudden cardiac death                                                                               69 (25.8%)               21 (15.2%)      
  Death from non-cardiac causes (*n* = 275)                                                                                                    
   Septic shock/infection                                                                             48 (13.6%)               29 (19.9%)       \< 0.001
   Acute renal failure                                                                                 23 (6.5%)               24 (16.4%)      
   Brain death/Hypoxic-ischaemic encephalopathy                                                       78 (22.1%)                1 (0.7%)       
   Stroke                                                                                              11 (3.1%)                6 (4.1%)       
   Respiratory                                                                                         18 (5.1%)                5 (3.4%)       
   Gastrointestinal                                                                                    12 (3.4%)                5 (3.4%)       
  Patients with a "do-not-resuscitate" order                                                          261 (73.7%)              131 (89.7%)      \< 0.001
  Comfort measures                                                                                    208 (58.8%)              121 (82.9%)      \< 0.001
  Vasoactive drugs during hospital admission                                                          319 (90.1%)              68 (46.6%)       \< 0.001
  Discontinuation of cardiac implantable defibrillator therapy (in defibrillator carriers)             7 (36.8%)               12 (75.0%)         0.584
  Mechanical ventilation                                                                              253 (71.5%)              15 (10.3%)       \< 0.001
  Non-invasive mechanical ventilation                                                                 59 (16.7%)               26 (17.8%)         0.794
  Mechanical circulatory support                                                                      88 (24.9%)                3 (2.1%)        \< 0.001
  Temporary pacemaker                                                                                 37 (10.5%)                6 (4.1%)          0.014
  Coronary angiography                                                                                184 (52.0%)              31 (21.1%)       \< 0.001
  Renal replacement therapy                                                                           42 (11.9%)                6 (4.1%)          0.007
  Therapeutic hypothermia                                                                             57 (16.2%)                2 (1.4%)        \< 0.001
  Opioids during admission                                                                            247 (70.4%)              125 (85.6%)      \< 0.001
  Length of hospital stay, days                                                                       10.0 ± 45.3              21.9 ± 36.7        0.005

Data are presented as means ± SD or *n* (%).

Half of the patients admitted after presenting a resuscitated cardiac arrest died due to neurologic injuries (hypoxic-ischemic encephalopathy). Mortality after resuscitated cardiac arrest had a biphasic pattern, with an early peak in the first 24 hours due to hemodynamic instability, and a second peak over the 5^th^ day, due to hypoxic encephalopathy ([Figure 1](#jgc-16-06-482-g001){ref-type="fig"}). [Table 3](#jgc-16-06-482-t03){ref-type="table"} shows the comparative analysis between patients with a previous "do-not-resuscitate" order and those with on-going therapy.

###### Basal demographic characteristics, previous medical history and mortality-related factors according to therapeutic effort.

  Variables                                                                                   Patients with a "do-not-resuscitate" order (*n* = 392)   Patients with on-going therapeutic efforts (*n* = 108)   *P*-value
  ------------------------------------------------------------------------------------------ -------------------------------------------------------- -------------------------------------------------------- -----------
  Age, yrs                                                                                                         75.1 ± 13.5                                              70.9 ± 12.8                          0.0029
  Female sex                                                                                                       148 (37.8%)                                               38 (35.2%)                           0.624
  Hypertension                                                                                                     303 (77.3%)                                               67 (63.8%)                           0.008
  Diabetes                                                                                                         157 (40.1%)                                               33 (31.4%)                           0.128
  New York Heart Association Functional Class \> II                                                                 84 (38.9%)                                               12 (21.1%)                           0.002
  History of ischemic heart disease                                                                                136 (34.7%)                                               26 (24.3%)                           0.048
  Previous valvular heart disease                                                                                  130 (33.3%)                                               16 (15.1%)                         \< 0.001
  Previous heart failure admissions                                                                                160 (40.8%)                                               23 (21.7%)                         \< 0.001
  Left ventricular ejection fraction                                                                              39.2% ± 17.3%                                            40.2% ± 17.6%                          0.634
  Atrial Fibrillation                                                                                              139 (35.6%)                                               21 (19.8%)                           0.002
  Cardiac devices                                                                                                                                                                                              
   Conventional pacemaker                                                                                           39 (10.0%)                                                7 (6.6%)                            0.054
   Implantable cardioverter defibrillator                                                                           31 (7.9%)                                                 2 (2.8%)                         
  Chronic kidney disease                                                                                           161 (41.1%)                                               21 (20.2%)                         \< 0.001
  Peripheral arterial disease                                                                                       73 (18.6%)                                               15 (14.4%)                           0.387
  Stroke with sequels                                                                                               45 (11.5%)                                                7 (6.7%)                            0.207
  Mild to moderate cognitive decline                                                                                32 (8.2%)                                                 5 (4.8%)                            0.299
  Most common diagnoses at admission                                                                                                                                                                           
   Acute coronary syndrome                                                                                          80 (20.4%)                                               35 (32.4%)                           0.001
   Cardiac arrest                                                                                                  114 (29.1%)                                               31 (28.7%)                        
   Heart failure                                                                                                   158 (40.3%)                                               23 (21.3%)                        
  Death from cardiac causes (*n* = 407)                                                                                                                                                                        
  Death from cardiac causes                                                                                        303 (77.3%)                                              104 (96.3%)                         \< 0.001
  Pump failure/Cardiogenic shock                                                                                   252 (64.3%)                                               15 (13.9%)                         \< 0.001
  Severe coronary ischemia                                                                                           7 (1.8%)                                                 1 (0.9%)                            0.502
  Sudden cardiac death                                                                                              21 (5.4%)                                                66 (61.1%)                         \< 0.001
  Death from non-cardiac causes (*n* = 275)\*                                                                                                                                                                  
   Septic shock/infection                                                                                           70 (17.9%)                                                7 (6.5%)                          \< 0.001
   Acute renal failure                                                                                              45 (11.5%)                                                2 (1.9%)                         
   Brain death/Hypoxic-ischaemic encephalopathy                                                                     77 (19.7%)                                                2 (1.9%)                         
   Stroke                                                                                                           15 (3.8%)                                                 2 (1.9%)                         
   Respiratory                                                                                                      18 (4.6%)                                                 5 (4.6%)                         
   Gastrointestinal                                                                                                 12 (3.1%)                                                 2 (0.5%)                         
  Comfort measures                                                                                                 326 (83.2%)                                                3 (2.8%)                          \< 0.001
  Vasoactive drugs during hospital admission                                                                       288 (73.5%)                                               99 (91.7%)                         \< 0.001
  Discontinuation of cardiac implantable defibrillator therapy (in defibrillator carriers)                          12 (31.6%)                                               2 (66.7%)                            0.232
  Mechanical ventilation                                                                                           177 (45.2%)                                               91 (84.3%)                         \< 0.001
  Non-invasive mechanical ventilation                                                                               81 (20.7%)                                                4 (3.7%)                          \< 0.001
  Mechanical circulatory support                                                                                    70 (17.9%)                                               21 (19.4%)                           0.676
  Temporary pacemaker                                                                                               30 (7.7%)                                                13 (12.0%)                           0.166
  Coronary angiography                                                                                             160 (40.8%)                                               55 (50.9%)                           0.061
  Renal replacement therapy                                                                                         42 (10.7%)                                                6 (5.6%)                            0.139
  Therapeutic hypothermia                                                                                           55 (14.1%)                                                3 (3.7%)                            0.002
  Opioids during admission                                                                                         342 (87.9%)                                               30 (27.8%)                         \< 0.001
  Place of death                                                                                                                                                                                               
   Conventional ward                                                                                               131 (33.4%)                                               15 (13.9%)                         \< 0.001
   Coronary unit                                                                                                   261 (66.6%)                                               93 (86.1%)                        
  Length of hospital stay, days                                                                                    15.8 ± 48.3                                               5.3 ± 11.4                          0.0264

Data are presented as means ± SD or *n* (%). \*Non-CV causes played a role in 275 patients (55.0%), non-CV causes were the leading cause of mortality in 93 patients (18.6%), and acted as an intervening cause of death in 182 (36.4%). CV: cardiovascular.

![Mortality during hospital admission in patients admitted after a resuscitated cardiac arrest.\
The bar height represents the percentage of patients admitted after a resuscitated cardiac arrest who died from each cause throughout the hospital admission (*n* = 145). Hospital mortality has been divided in three periods: ≤ 24 h, 2--4 days, and ≥ 5 days.](jgc-16-06-482-g001){#jgc-16-06-482-g001}

Treatments administered during the last 24 hours of life are depicted in [Figure 2](#jgc-16-06-482-g002){ref-type="fig"}. About a quarter of patients received inotropes, antibiotics, or antiplatelet agents. A total of 40 patients had an implantable cardioverter defibrillator, but information about therapies deactivation was only registered in the medical records of 14 patients (34.2%).

![Rate of treatment administration in the last 24 h of life.\
DNR: do-not-resuscitate.](jgc-16-06-482-g002){#jgc-16-06-482-g002}

The independent predictors associated with limitation of therapeutic effort, and comfort measures administrations before death are depicted in [Table 4](#jgc-16-06-482-t04){ref-type="table"}. After adjusting for clinical characteristics and comorbidities, the strongest predictors of withdrawing life-sustaining therapies were heart failure or hypoxic-ischemic encephalopathy. Death due to CV causes (except death due to pump failure) was associated with a lower probability of both a "do-not-resuscitate" order, and comfort measures administration before death.

###### Independent predictors of limitation of therapeutic effort and administration of comfort treatments before death.

                                                                    OR (95% CI)        *P*-value
  ------------------------------------------------------------ ---------------------- -----------
  Limitation of therapeutic effort                                                    
   Age                                                           1.02 (1.01--1.05)       0.044
   Chronic kidney disease                                         2.1 (1.01--4.31)       0.048
   Previous ischemic heart disease                               2.13 (1.01--4.46)       0.046
   Diagnosis of heart failure at admission                       2.60 (1.34--5.04)       0.005
   Death due to CV causes                                        0.10 (0.03--0.32)     \< 0.001
   Death due to pump failure                                     11.5 (5.01--26.56)    \< 0.001
   Death due to sudden death                                     0.23 (0.10--0.55)       0.001
   Death due to brain death/Hypoxic-ischaemic encephalopathy    11.90 (2.32--61.00)      0.003
  Comfort measures before death                                                       
   Age                                                           1.01 (1.009--1.04)      0.005
   Chronic kidney disease                                        2.19 (1.38--3.46)       0.001
   Diagnosis of heart failure                                    3.52 (2.07--6.00)     \< 0.001
   Death due to brain death/Hypoxic-ischaemic encephalopathy     5.45 (2.53--11.77)    \< 0.001
   Death due to pump failure                                    24.61 (13.83--43.78)   \< 0.001

CI: confidence interval; OR: odds ratio.

Patients dying with heart failure presented the longest length of hospital stay (15.3 ± 29.7 days). After excluding heart failure deaths, duration of hospital admission tended to be shorter in patients who died due to a CV cause (5.6 ± 11.0 days), compared to those with a non-CV cause of death (20.4 ± 43.2 days), *P* = 0.04.

4. Discussion {#s4}
=============

Our study shows that more than three quarters of the deaths occurring in a cardiology department occur in patients with a prior "do-not-resuscitate" order. "Pump failure" is the most common cause of death, but non-CV causes are also frequent. Limitation of therapeutic effort is more frequent in patients admitted with heart failure than in those admitted due to cardiac arrest or acute coronary syndrome. Heart failure patients also received more comfort measures before death than those hospitalized for other reasons. Patients who died in the cardiac intensive care unit received less comfort measures/palliative interventions before death than those admitted to the conventional ward.

As it was expected, patients with a "do-not-resuscitate" order were older, and presented more associated CV diseases and comorbidities. It is remarkable that dying due to a CV cause was associated with a lower rate of therapeutic withdrawal, compared to a non-CV cause. This observation has also been found in previous studies.[@b11],[@b12] A proposed explanation is that patients who die due to a CV condition are more likely to present hemodynamic instability leading to a rapid death, and consequently, a shorter length of hospital stay.[@b12] By contrast, non-CV deaths are often related to intractable multiorgan failure,[@b12],[@b13] and can be easily predicted.

We have found that nearly 90% deaths in the conventional ward were expected (occurred after withholding a treatment procedure due to perceived futility) and consequently, therapeutic efforts had been limited before death. A similar proportion has been found in a previous study performed in an internal medicine ward.[@b14] In our cardiac intensive care unit, about three quarters of patients who died had a prior "do-not-resuscitate" order. This proportion contrasts with the significantly lower percentage of patients who received a palliative approach and comfort measures (interventions aimed at providing an immediate relief of symptoms), which did not reach 60% of deaths at the cardiac intensive care unit. The limitation of therapeutic effort in the intensive care unit is still a pending issue,[@b15] and palliative care is frequently not incorporated into daily clinical practice despite its proven efficacy.[@b16],[@b17] It has been estimated that about one in five deaths documented in the United States may occur in a critical care bed,[@b15] but in our cardiology department such proportion was higher (nearly three quarters).

Decisions regarding withholding/withdrawing life-sustaining therapies take into account several factors and vary widely between geographical areas.[@b18] In this sense, prognostic information is crucial,[@b15] and this fact was consistent with the findings of our study, as the two strongest predictors regarding limitation of therapeutic effort were dying due to hypoxic encephalopathy and terminal heart failure. As we have noted in this registry, admissions after presenting a resuscitated cardiac arrest accounted for approximately one third of the deaths, and in this group hypoxic encephalopathy was the main reason of death. By contrast, although cognitive impairment has traditionally been an independent predictor of therapeutic effort limitation,[@b19] this was not the case in our study. Patients who died in our department were mainly male. This fact could be explained by the higher prevalence of CV disease in men,[@b20] and also a greater frailty in women;[@b21],[@b22] who would be probably referred to other wards, such as internal medicine or geriatrics.

Regarding patients who were admitted due to heart failure, death due to "pump failure" or terminal heart failure was the most common cause of death, as it has been previously described.[@b2],[@b23]--[@b25] These patients had common comorbidities and received lesser aggressive treatments at the end of life than patients who died of other causes or had different diagnoses at admission.

There seems to be field for improvement. For example, in carriers of implantable cardioverter defibrillators, a written record of deactivation was only found in a minority of cases, despite the previous decision to limit the therapeutic effort. This situation has also been described in a previous experience.[@b26] In this sense, it is important to involve in an early phase all the professionals who take care of these patients.[@b26] In addition, there was a very high prescription of medications that can be considered futile in patients with a limited life expectancy and a near death.

4.1. Limitations {#s4a}
----------------

This study has some limitations. The presented data correspond to the experience of a single center, and there could be differences with other cardiology departments. In addition, our study analyses only the deaths during admission and no information was collected from other patients. However, our study provides detailed information about the causes of mortality, end-of-life management, and suggests opportunities for future improvement, especially in patients with end-stage heart disease.

4.2. Conclusions {#s4b}
----------------

More than three quarters of the deaths occurring in a cardiology department occurs in patients with a previous "do-not-resuscitate" order, but not all patients receive comfort or palliative measures before death. We have found a high prescription of life-sustaining therapies the last 24 hours of life. Heart failure was the most frequent diagnosis and the limitation of therapeutic effort was more common in this group than in the rest of diagnoses. Patients who died in the cardiac intensive care unit received less palliative measures before death.
